Online citations, reference lists, and bibliographies.
← Back to Search

Uptake And Transport Of Insulin Across Intestinal Membrane Model Using Trimethyl Chitosan Coated Insulin Niosomes.

Saeid Moghassemi, Ehsan Parnian, Amirhossien Hakamivala, M. Darzianiazizi, Marzieh Mowlavi Vardanjani, S. Kashanian, B. Larijani, K. Omidfar
Published 2015 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This study reports the development of a highly stable niosomal nanostructure based on Span 60/cholesterol (CH)/N-trimethyl chitosan (TMC) system and its potential application for oral delivery of insulin. Insulin loaded niosomes were prepared by reversed-phase evaporation and TMC coating was performed by incubation of niosomal suspensions with TMC solution. The efficiency of nanoparticulate delivery system in enhancement of insulin permeation was evaluated by Caco-2 cell monolayer as intestinal membrane models. The prepared niosomes were characterized for entrapment efficiency (EE), particle size, zeta potential and stability. The particles were between 100 and 180 nm in diameter, and they were stable for over 60 days at 4 °C. Insulin permeability through Caco-2 cell monolayer was enhanced 4-fold by niosomal nanoparticles, compared with insulin alone. Further work is demanded to optimize this formulation with the object of maximizing its potential to facilitate oral delivery of insulin.
This paper references
10.1016/J.COLSURFA.2006.07.053
Structure behaviors of hemoglobin in PEG 6000/Tween 80/Span 80/H2O niosome system
Tianqing Liu (2007)
10.1007/S10856-007-3193-4
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides
Yongzhuo Huang (2008)
The selection of terms in responsesurface model — how strong is the weakheredity principle ?
J. A. Nelder (2010)
10.1016/j.talanta.2008.05.019
Response surface methodology (RSM) as a tool for optimization in analytical chemistry.
Marcos Almeida Bezerra (2008)
10.1016/J.APSB.2011.09.002
Nonionic surfactant vesicular systems for effective drug delivery—an overview
G. P. Kumar (2011)
Response surface methodology (RSM) as a tool for optimization in analytical chemistry, Talanta
M. A. Bezerra (2008)
Preparation and properties of highly stable innocuous niosome in Span 80 / PEG 400 / H 2 O system , Colloids Surf
T. Liu W. Hua (2008)
10.1016/j.biomaterials.2011.08.087
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
M. Chen (2011)
10.1016/S1461-5347(98)00059-5
Pharmaceutical applications of chitosan
V. Dodane (1998)
Nanosuspension Formulation: An Improved
V. B. Kavitha (2013)
10.1023/A:1007558206506
N-Trimethylated Chitosan Chloride (TMC) Improves the Intestinal Permeation of the Peptide Drug Buserelin In Vitro (Caco-2 Cells) and In Vivo (Rats)
M. Thanou (2004)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1016/J.VACCINE.2006.06.086
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
M. Amidi (2007)
10.1016/j.ijpharm.2008.05.031
Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
M. Mokhtar (2008)
10.1016/j.jconrel.2014.04.015
Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Saeid Moghassemi (2014)
Pharmacokinetic study of niosome-loaded insulin in diabetic rats
A. Pardakhty (2011)
10.1016/J.CARBPOL.2007.10.023
Synthesis of methylated chitosan containing aromatic moieties: Chemoselectivity and effect on molecular weight
W. Sajomsang (2008)
10.1208/s12249-011-9716-9
Preparation, Statistical Optimization, and In vitro Characterization of Insulin Nanoparticles Composed of Quaternized Aromatic Derivatives of Chitosan
R. Mahjub (2011)
10.1089/hyb.2010.0090
Development of a colloidal gold-based immunochromatographic test strip for screening of microalbuminuria.
K. Omidfar (2011)
Niosomes in targeted drug delivery — a review
P. Gadhiya (2012)
Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Z. Wu (2004)
The selection of terms in responsesurface model — how strong is the weakheredity principle ?
J. A. Nelder (2010)
10.1016/J.CHROMA.2007.03.051
Statistical designs and response surface techniques for the optimization of chromatographic systems.
S. Ferreira (2007)
10.3109/03639049809089942
Chitosan: a unique polysaccharide for drug delivery.
O. Felt (1998)
10.1016/j.ijpharm.2010.10.027
Entrapment and release difference resulting from hydrogen bonding interactions in niosome.
Y. Hao (2011)
10.1007/s10856-008-3659-z
Trimethyl chitosan and its applications in drug delivery
V. Mourya (2009)
10.1007/s11705-013-1306-9
Overcoming oral insulin delivery barriers: application of cell penetrating peptide and silica-based nanoporous composites
Huining He (2013)
10.1016/j.biomaterials.2010.12.044
The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
Ho-Ngoc Nguyen (2011)
NIOSOMES: A NOVEL DRUG DELIVERY SYSTEM
H. Kaur (2012)
NIOSOMES - A NOVEL DRUG DELIVERY DEVICE
S. Gopalakrishnan (2012)
10.1081/IAS-120013035
STABILIZATION OF PENICILLINASE-HAPTEN CONJUGATE FOR ENZYME IMMUNOASSAY
K. Omidfar (2002)
Nanosuspensions: A Promising Drug Delivery Strategy
V. Shinde (2010)
10.1016/S0939-6411(02)00062-0
Liposomes produced in a pilot scale: production, purification and efficiency aspects.
A. Wagner (2002)
10.1016/S0168-3659(99)00131-5
Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
M. Thanou (2000)
10.1016/J.COLSURFA.2007.02.068
Preparation and properties of highly stable innocuous niosome in Span 80/PEG 400/H2O system
W. Hua (2007)
10.1016/J.CARBPOL.2011.02.018
N,N,N-Trimethyl chitosan nanoparticles for the delivery of monoclonal antibodies against hepatocellular carcinoma cells.
P. Vongchan (2011)
10.1080/00031305.1998.10480588
The Selection of Terms in Response-Surface Models—How Strong is the Weak-Heredity Principle?
J. Nelder (1998)
Liposomes produced in a pilot scale : production , puri fi cation and ef fi ciency aspects , Eur
K. Vorauer-Uhl A. Wagner (1999)
10.1016/j.addr.2012.10.007
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
Insulin drug delivery: novel approaches
V. Sharma (2013)
10.1016/j.ijpharm.2011.04.003
Facilitated nanoscale delivery of insulin across intestinal membrane models.
Camile B. Woitiski (2011)
10.2147/NANO.2006.1.2.117
Chitosan nanoparticles for oral drug and gene delivery
Katherine Bowman (2006)
10.1007/s001250050709
Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits
B. Nordestgaard (1997)
10.22037/IJPR.2010.774
Formulation and Optimization of Captopril Sublingual Tablet Using D-Optimal Design
N. Bolourtchian (2008)
10.1007/978-1-4020-6289-6_4
Niosomes as Nanocarrier Systems
N. Sahin (2007)
10.1016/S0378-5173(02)00301-0
Studies on a high encapsulation of colchicine by a niosome system.
Y. Hao (2002)
10.1007/12_2011_117
Chitosan and Its Derivatives for Drug Delivery Perspective
C. P. Sharma (2011)
10.1016/j.bios.2011.04.022
Development of urinary albumin immunosensor based on colloidal AuNP and PVA.
K. Omidfar (2011)
10.1016/S0378-5173(98)00169-0
Non-ionic surfactant based vesicles (niosomes) in drug delivery
I. Uchegbu (1998)
Nanoparticle vesicular systems : A versatile tool for drug delivery
S. Verma (2010)
Non invasive insulins: advanced insulin therapy over this decade
T. Rajeswari (2011)
10.1089/1520915041705929
The physiological rationale for oral insulin administration.
E. Arbit (2004)
10.1016/S0168-3659(99)00073-5
Preparation and characterization of protein C-loaded PLA nanoparticles.
M. Zambaux (1999)
10.1016/j.ijpharm.2007.11.052
Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
A. Sadeghi (2008)



This paper is referenced by
Niosomes as Nanoparticular Drug Carriers : Fundamentals and Recent Applications
D. A. Şeleci (2016)
10.1080/03639045.2020.1810269
Niosomal delivery of simvastatin to MDA-MB-231 cancer cells
I. Akbarzadeh (2020)
10.1155/2016/7372306
Niosomes as Nanoparticular Drug Carriers
D. A. Şeleci (2016)
10.1016/j.abb.2020.108643
pH-bioresponsive poly(ε-caprolactone)-based polymersome for effective drug delivery in cancer and protein glycoxidation prevention.
F. Ghorbanizamani (2020)
10.1080/08982104.2019.1652646
Preparation and evaluation of transdermal naproxen niosomes: formulation optimization to preclinical anti-inflammatory assessment on murine model
D. Mohanty (2019)
10.1208/s12249-016-0579-y
Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization
Saeid Moghassemi (2016)
10.2174/1389450120666190307101642
Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus.
A. M. Mohsen (2019)
10.1557/ADV.2018.455
Structural Characteristics and Diffusion Coefficient of Alginate Hydrogels Used for Cell Based Drug Delivery
A. Najdahmadi (2018)
10.1016/j.ijpharm.2016.12.018
Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
A. Kassem (2017)
10.1016/j.bioorg.2020.104231
Preparation and optimization of ciprofloxacin encapsulated niosomes: A new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus.
A. Mirzaie (2020)
10.1049/iet-nbt.2015.0022
Signal amplification strategy using gold/N-trimethyl chitosan/iron oxide magnetic composite nanoparticles as a tracer tag for high-sensitive electrochemical detection.
H. Shirazi (2016)
Applications of Niosome and Targeting Strategies in the Field of Phyto-Pharmaceuticals : A Review
E. Patra (2018)
10.1039/C6CS00409A
Lipid-based nanovesicles for nanomedicine.
N. Grimaldi (2016)
Chitosan-mediated vaccine delivery through the intestinal epithelium
Hannah Cole (2016)
10.1016/j.ejps.2016.09.002
Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein.
Muhammad Imran Khan (2016)
10.1016/j.jddst.2020.101863
Preparation and characterization of anticancer niosomal withaferin–A formulation for improved delivery to cancer cells: In vitro, in vivo, and in silico evaluation
Hamid Saeed Shah (2020)
10.1208/s12249-016-0487-1
Formulation and Characterization of Bovine Serum Albumin-Loaded Niosome
Saeid Moghassemi (2016)
10.1016/j.colsurfb.2015.01.035
Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats.
R. Sharma (2015)
10.1016/j.ijbiomac.2019.07.003
Potential effect of carnosine encapsulated niosomes in bovine serum albumin modifications.
Hichem Moulahoum (2019)
Synthesis and Immunogenisity Evaluation of Tetanus Toxoid Encapsulated Trimethyl Chitosan Nanoparticles
Majdedin Ghalavand (2017)
10.1016/j.carbpol.2016.10.041
N,N,N-Trimethyl chitosan: An advanced polymer with myriad of opportunities in nanomedicine.
A. Kulkarni (2017)
10.1016/J.SNB.2015.07.021
A high sensitive electrochemical nanoimmunosensor based on Fe3O4/TMC/Au nanocomposite and PT-modified electrode for the detection of cancer biomarker epidermal growth factor receptor
K. Omidfar (2015)
10.1016/j.ijpharm.2016.08.002
Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studies.
C. Ingallina (2016)
10.1016/j.biopha.2017.06.043
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Mohd Qumbar (2017)
10.1016/j.jddst.2020.101896
Chitosan-decorated nanoparticles for drug delivery
M. L. D. Prado-Audelo (2020)
10.1016/j.reactfunctpolym.2019.104459
Chitosan as a coating material for nanoparticles intended for biomedical applications
L. A. Frank (2020)
10.1016/j.jconrel.2020.02.041
Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes.
Delaram Babadi (2020)
10.1016/j.jconrel.2017.04.038
Lipophilic peptide character - What oral barriers fear the most.
O. Zupančič (2017)
10.1088/2057-1976/AB1C3D
Modeling and optimization of the niosome nanovesicles using response surface methodology for delivery of insulin
Amirhossein Hakamivala (2019)
10.1016/J.PMATSCI.2017.05.001
Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
Francisca Araújo (2017)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.1016/j.diabres.2017.11.018
Nanotechnology based approaches for anti-diabetic drugs delivery.
P. Kesharwani (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar